Kevin Bailey has 25 years of experience in the biopharmaceutical industry, 20 of those at Regeneron Pharmaceuticals, Inc., where he is Vice President of Preclinical Manufacturing and Process Development. He is responsible for leading all development efforts for clinical and commercial-scale manufacturing processes for all antibodies and other products in Regeneron Pharmaceuticals expanding development pipeline. He received his Ph.D. in biochemical engineering from Rutgers University in 1987.
Notice: The AIChE website is undergoing an ecommerce system upgrade to better serve you. Between 7 a.m. (EST) Friday, December 6 and 9 a.m. (EST) Monday, December 9 you will not be able to purchase or renew any AIChE products or services through the website. Customer Service phone lines are open 9 a.m. to 5 p.m. Monday through Friday... Learn more